title: [Update of planning tables of cholesterol-lowering therapy orientated to achieve LDL therapeutic targets].
abstract: This is the third update of a planning-table for use in cholesterol-lowering therapy, so as to obtain LDLc objectives. This is an easy to use laptop tool to help choose the best statin or combination therapy (statin plus ezetimibe) depending on the current LDL concentration of the patient, and the LDLc objective to achieve. It is based on a colour code that indicates the drugs that are efficient enough to help patients to achieve their LDL goal. Along with the table, recommendations are given for the best strategy in order to implement the optimal therapy in a maximum of two clinical encounters.
authors: Unitat de Medicina Vascular i Metabolisme, Hospital Universitari Sant Joan, IISPV, CIBERDEM, Universitat Rovira i Virgili, Reus, España, Reus, Tarragona, España. Electronic address: luis.masana@urv.cat.
authors: Luis
authors: L
authors: Masana
authors: Unitat de Medicina Vascular i Metabolisme, Hospital Universitari Sant Joan, IISPV, CIBERDEM, Universitat Rovira i Virgili, Reus, España, Reus, Tarragona, España.
authors: Núria
authors: N
authors: Plana
mesh_terms: D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008078:Cholesterol, LDL / Q000097:blood*; D004359:Drug Therapy, Combination; D000069438:Ezetimibe / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000188:drug therapy*; D017410:Practice Guidelines as Topic
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000069438:Ezetimibe
keywords: Cholesterol; Cholesterol-lowering treatment; Colesterol; Estatinas; Ezetimiba; Ezetimibe; LDL; Objetivos terapéuticos; Statins; Therapeutic objectives; Tratamiento hipolipemiante